Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02779075 · ClinicalTrials.gov registry record · NA

Exendin-9,39 and Satiety After Bariatric Surgery

A NA study of Obesity, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
29
Enrollment target
1
Study location

NCT02779075: Completed NA study of Obesity, sponsored by Mayo Clinic.

NCT02779075 is a NA study of Obesity that has completed, run by Mayo Clinic. The registered enrollment target is 29 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02779075, a NA study of Obesity, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target
1
Study location

Study Summary

The overall aim of the application is to determine the contribution of the elevated incretin hormone concentrations seen after certain types of bariatric surgery to the regulation of food intake and satiety.

Conditions Studied

Obesity

Interventions

  • DRUG Saline
  • DRUG Exendin-9,39

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2016-06
Est. Completion 2019-12
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02779075

The ClinicalTrials.gov registry entry for NCT02779075 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (96% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.

NCT02779075 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT02779075 about?

NCT02779075 is a clinical study titled "Exendin-9,39 and Satiety After Bariatric Surgery". The overall aim of the application is to determine the contribution of the elevated incretin hormone concentrations seen after certain types of bariatric surgery to the regulation of food intake and satiety.

What is the current status of trial NCT02779075?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2016-06. Estimated completion is 2019-12.

What conditions does trial NCT02779075 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT02779075?

The interventions under investigation include: Saline (DRUG), Exendin-9,39 (DRUG).

Who is sponsoring clinical trial NCT02779075?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02779075 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Obesity

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.